{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:16:21Z","timestamp":1761164181326,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cld.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:56:16Z","timestamp":1691801776000},"page":"157-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic Tests in Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"28","author":[{"given":"Clara Y.","family":"Tow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarpreet","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett E.","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2023.07.007_bib1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.07.007_bib2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-9343(81)90857-3","article-title":"Pruritis in cholestasis: no direct causative role for bile acid retention","volume":"70","author":"Freedman","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2023.07.007_bib3","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1007\/BF02087659","article-title":"Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Kodley","year":"1994","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2023.07.007_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","author":"Xu","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.07.007_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(87)80055-7","article-title":"An autoantibody profile in primary sclerosing cholangitis","volume":"5","author":"Zauli","year":"1987","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis in primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2023.07.007_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1590-8658(01)80099-2","article-title":"Autoimmune serology of primary sclerosing cholangitis","volume":"33","author":"Zauli","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2023.07.007_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/tan.13076","article-title":"HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry","volume":"90","author":"Henriksen","year":"2017","journal-title":"HLA"},{"key":"10.1016\/j.cld.2023.07.007_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/0891693021000054093","article-title":"Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis","volume":"35","author":"Donaldson","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cld.2023.07.007_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spukland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.cld.2023.07.007_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2006.01.002","article-title":"Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases","volume":"119","author":"Zachou","year":"2006","journal-title":"Clin Imunol"},{"key":"10.1016\/j.cld.2023.07.007_bib13","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.26977","article-title":"Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis","volume":"59","author":"Boonstra","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12876-019-1075-0","article-title":"Association between serum IgG level and clinical course in primary sclerosing cholangitis","volume":"19","author":"Hippchen","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cld.2023.07.007_bib15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2023.07.007_bib16","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.07.007_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2005.11.031","article-title":"Serum igG4 concentrations in pancreatic and biliary diseases","volume":"367","author":"Hirano","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cld.2023.07.007_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy","volume":"18","author":"Bj\u00f6rnsson","year":"2001","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.cld.2023.07.007_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","article-title":"IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis","volume":"34","author":"Zhang","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cld.2023.07.007_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2017.05.018","article-title":"Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC\/AIH and PSC alone","volume":"16","author":"Lian","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2023.07.007_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib22","first-page":"439","article-title":"Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC-and multivariate regression analysis","volume":"9","author":"Terjung","year":"2004","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cld.2023.07.007_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.07.007_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9343(98)00294-0","article-title":"Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features","volume":"105","author":"Roozendaal","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2023.07.007_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.48.10.933","article-title":"Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis","volume":"48","author":"Olsson","year":"1995","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.007_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib29","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2023.07.007_bib30","doi-asserted-by":"crossref","first-page":"e0164224","DOI":"10.1371\/journal.pone.0164224","article-title":"Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis","volume":"11","author":"Ehlken","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2023.07.007_bib31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.22577","article-title":"Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis","volume":"48","author":"Millonig","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib32","first-page":"1854","article-title":"Liver elastography in primary sclerosing cholangitis patients using three different scanner systems","volume":"46","author":"Mjelle","year":"2020","journal-title":"Ultrasound"},{"key":"10.1016\/j.cld.2023.07.007_bib33","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ultrasmedbio.2016.04.016","article-title":"Ultrasound and point shear wave elastography in livers of patients with primary sclerosing cholangitis","volume":"42","author":"Mjelle","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.cld.2023.07.007_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systemic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00261-022-03529-x","article-title":"MR elastography in primary sclerosing cholangitis: a pictorial review","volume":"48","author":"Welle","year":"2023","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.cld.2023.07.007_bib36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jgh.13263","article-title":"Performance of magnetic resonance elastography in primary sclerosing cholangitis","volume":"31","author":"Eaton","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00330-018-5619-4","article-title":"The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis","volume":"29","author":"Jhaveri","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cld.2023.07.007_bib38","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1148\/rg.2019180213","article-title":"Imaging features of primary sclerosing cholangitis: from diagnosis to liver transplant follow-up","volume":"39","author":"Khoshpouri","year":"2019","journal-title":"Radiographics"},{"key":"10.1016\/j.cld.2023.07.007_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00201514","article-title":"Primary sclerosing cholangitis: sonographic findings","volume":"20","author":"Majoie","year":"1995","journal-title":"Abdom Imaging"},{"issue":"1","key":"10.1016\/j.cld.2023.07.007_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3348\/kjr.2009.10.1.25","article-title":"Sclerosing cholangitis: clinicopathologic features, imaging spectrum, and systemic approach to differential diagnosis","volume":"17","author":"Kim","year":"2016","journal-title":"Korean J Radiol"},{"issue":"2","key":"10.1016\/j.cld.2023.07.007_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib42","first-page":"2372257","article-title":"ERCP-related adverse events in primary sclerosing cholangitis: a systemic review and meta-analysis","volume":"2022","author":"Natt","year":"2002","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"AJG"},{"key":"10.1016\/j.cld.2023.07.007_bib44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.gie.2014.06.030","article-title":"ERCP-related adverse events in patients with primary sclerosing cholangitis","volume":"81","author":"Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2023.07.007_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.livres.2019.03.004","article-title":"Biliary endoscopy in the management of primary sclerosing cholangitis and its complications","volume":"3","author":"Fung","year":"2019","journal-title":"Liver Res"},{"key":"10.1016\/j.cld.2023.07.007_bib46","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/MCG.0b013e3181646713","article-title":"A\u00a0twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis","volume":"42","author":"Gluck","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2023.07.007_bib47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gie.2007.07.042","article-title":"Complications after ERCP in patients with primary sclerosing cholangitis","volume":"67","author":"Etzel","year":"2008","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2023.07.007_bib48","first-page":"24","article-title":"Antibiotic prophylaxis and its effect on postprocedural adverse events in endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis","volume":"5","author":"Gustafsson","year":"2022","journal-title":"JGH Open"},{"key":"10.1016\/j.cld.2023.07.007_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2005.12.034","article-title":"Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography","volume":"64","author":"Moff","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2023.07.007_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2023.07.007_bib51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-2008-1077509","article-title":"Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Weber","year":"2008","journal-title":"Endoscopy"},{"key":"10.1016\/j.cld.2023.07.007_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.215.1.r00ap2671","article-title":"Primary sclerosing cholangitis: evaluation with MR cholangiography \u2013 a case-control study","volume":"215","author":"Fulcher","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.cld.2023.07.007_bib53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.20287","article-title":"Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis","volume":"40","author":"Talwalkar","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib55","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2007-966253","article-title":"The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis","volume":"39","author":"Meagher","year":"2007","journal-title":"Endoscopy"},{"key":"10.1016\/j.cld.2023.07.007_bib56","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cld.2023.07.007_bib57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2023.07.007_bib58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib59","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.28963","article-title":"Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: an international cohort study","volume":"65","author":"de Vries","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2023.07.007_bib60","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2015.06.008","article-title":"Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis","volume":"63","author":"de Vries","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2023.07.007_bib61","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/his.14677","article-title":"Novel histologic scoring for predicting disease outcome in primary sclerosing cholangitis","volume":"81","author":"Sj\u00f6blom","year":"2002","journal-title":"Histopathology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326123000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:01:16Z","timestamp":1761069676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326123000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1089326123000879"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Tests in Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}